1st Circuit Asked To Decide Whether Court Properly Dismissed Securities Claims

(February 17, 2017, 9:44 AM EST) -- BOSTON — Parties in a securities class action lawsuit against a drug maker and certain of its executive officers recently asked the First Circuit U.S. Court of Appeals to determine whether a federal district court erred in dismissing the lead plaintiff’s amended complaint for failure to plead scienter and abused its discretion in denying the lead plaintiff’s motion to vacate the dismissal order (In re Biogen Inc. Securities Litigation, No. 16-1976, 1st Cir.)....